Family Medicine · Pleasant Grove, UT
NPI
1194833475
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
830 N 2000 W
Pleasant Grove, UT, 84062
Phone (801) 756-3511
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
1,633 services
Medicare patients, 2024
250
Average age 73
Drug cost, 2024
$513K
7,554 prescriptions
Company payments, 2025
$769
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marshall F Willis was code 99214 (office e&m - established), 423 times for 212 patients. In total Marshall F Willis billed 1,633 services in 83 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 423 | 212 | $81.07 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 206 | 112 | $10.76 | $2,218 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 160 | 160 | $122.17 | $20K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 154 | 154 | $17.35 | $2,673 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 84 | 24 | $0.58 | $48.59 |
| 99213 Office E&M - Established | Office | 65 | 58 | $56.59 | $3,678 |
| 81003 Clinical Chemistry | Office | 55 | 40 | $2.20 | $121 |
| 83036 Blood Count | Office | 53 | 37 | $9.47 | $502 |
| G0008 Administration of influenza virus vaccine | Office | 45 | 45 | $30.87 | $1,389 |
| 90662 Vaccine Product | Office | 45 | 45 | $80.50 | $3,623 |
| 90480 Vaccine Administration | Office | 28 | 27 | $39.69 | $1,111 |
| 91320 Vaccine Product | Office | 28 | 27 | $143.85 | $4,028 |
| 17110 Destruction Skin Lesion | Office | 20 | 18 | $71.46 | $1,429 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 18 | 15 | $154.06 | $2,773 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 14 | 14 | $157.06 | $2,199 |
By year: 2022 $62K for 1,423 services; 2023 $75K for 1,346 services; 2024 $89K for 1,633 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 55 | 40 | $2.20 | $121 |
| 83036 Blood Count | 53 | 37 | $9.47 | $502 |
Medicare prescription drug claims, 2024
In 2024, the drug Marshall F Willis prescribed most often to Medicare patients was Omeprazole, with 305 prescriptions and refills. In total Marshall F Willis wrote 7,554 Medicare prescriptions that cost $513K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 305 | 893 | 99 | $6,927 |
| Levothyroxine Sodium Generic | 292 | 873 | 86 | $4,149 |
| Atorvastatin Calcium Generic | 246 | 744 | 81 | $3,030 |
| Rosuvastatin Calcium Generic | 218 | 655 | 72 | $3,833 |
| Zolpidem Tartrate Generic | 188 | 213 | 37 | $1,489 |
| Gabapentin Generic | 185 | 475 | 72 | $4,812 |
| Simvastatin Generic | 153 | 479 | 43 | $2,543 |
| Meloxicam Generic | 153 | 347 | 53 | $1,119 |
| Amlodipine Besylate Generic | 147 | 399 | 42 | $1,575 |
| Tamsulosin Hcl Generic | 146 | 393 | 49 | $2,667 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 142 | 417 | 47 | $2,630 |
| Metformin Hcl Generic | 130 | 383 | 42 | $1,958 |
| Diclofenac Sodium Generic | 129 | 257 | 57 | $2,718 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 123 | 123 | 31 | $1,416 |
| Losartan Potassium Generic | 123 | 378 | 37 | $1,725 |
Brand drugs: 653 claims; generic drugs: 6,856 claims; opioid claims: 274.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marshall F Willis $769 ($769 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $297.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $297 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $86.12 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $73.57 |
| Viatris Specialty LLC | 2 | $39.69 |
| Boston Scientific Corporation BSX | 2 | $33.08 |
| Pfizer Inc. PFE | 2 | $31.46 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $30.86 |
| GlaxoSmithKline, LLC. GSK | 2 | $29.43 |
| Edwards Lifesciences Corporation EW | 1 | $28.75 |
| Astellas Pharma US Inc 4503.T | 1 | $26.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.